Mr. McCaslin’s presentation discussed the role of intellectual property in personalized medicine. In particular, the program provided an overview of the patenting process and present strategies for securing global patent protection. We also discussed the impact of recent court cases on theranostic patent and propose tactics for navigating the minefield.
For more information on Mr. McCaslin’s presentation and the conference program, please visit http://www.personalizedmedicinepartnerships.com/.
Related Insights
January 15, 2026
The Path & The Practice
Special Episode: Alexis Robertson and Dan Sharpe talk advice to new Big Law associates
In this special edition of The Path & The Practice, Alexis is joined by Dan Sharpe, DEI Manager at Foley & Lardner, for a conversation focused on advice to new associates. Based on their years of legal practice and their experience working in law firm talent development and DEI, they cover a variety of topics including time entry, meeting deadlines, responsiveness, and office presence.
January 14, 2026
Health Care Law Today
Protecting the AI Advantage: Why Patents Are a Critical Growth and Risk-Management Tool for Digital Health Platforms
For CEOs, general counsels, and CTOs, the question is no longer whether patents matter. The question is whether the company has an…
February 23, 2026
Events
International Consumer Products Health and Safety Organizaton 2026 Annual Meeting and Training Symposium
On February 23-26, the International Consumer Products Health and Safety Organization (ICPHSO) will host its 33rd Annual Meeting and Training Symposium in Orlando, Florida. This flagship event brings together global product safety professionals for four days of collaboration, learning, and networking.